Showing results (211-220 of 300) with videos related to

Sort By:
Pageof 30
Nature Communications|August 23, 2024
Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 studyXiaojing Xu, Luoyan Ai, Keshu Hu, et al.
Oncogenesis|September 21, 2022
Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathwayMengling Liu, Xiaojing Xu, Ke Peng, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 22, 2015
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancerJinwan Wang, Ruihua Xu, Jian Li, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 15, 2024
Association of Glycemic Control With Right Ventricular Function Assessed by Two-Dimensional Speckle-Tracking and Three-Dimensional Echocardiography in Type 2 Diabetes MellitusYanting Zhang, Yuman Li, Yixia Lin, et al.
Translational Andrology and Urology|March 6, 2020
Microenergy acoustic pulses induced myogenesis of urethral striated muscle stem/progenitor cellsKai Cui, Ning Kang, Lia Banie, et al.
Nature Communications|October 15, 2024
Nivolumab plus anlotinib hydrochloride in advanced gastric adenocarcinoma and esophageal squamous cell carcinoma: the phase II OASIS trialJing Wu, Shilong Zhang, Shan Yu, et al.
International Journal of Biological Sciences|January 3, 2023
PROX1-mediated epigenetic silencing of <i>SIRT3</i> contributes to proliferation and glucose metabolism in colorectal cancerLu Gan, Qingguo Li, Wei Nie, et al.
BMC Cancer|March 15, 2017
A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancerXin Liu, Weijian Guo, Wen Zhang, et al.
Trends in Cardiovascular Medicine|April 24, 2022
New trends in non-pharmacological approaches for cardiovascular disease: Therapeutic ultrasoundTianshu Liu, Jiawei Shi, Yanan Fu, et al.
Cell Death & Disease|July 13, 2024
IL-4/IL-4R axis signaling drives resistance to immunotherapy by inducing the upregulation of Fcγ receptor IIB in M2 macrophagesJiayu Zhang, Yu Dong, Shan Yu, et al.
Pageof 30